Management of gastro-oesophageal reflux disease in primary care: A European observational study

Current Medical Research and Opinion

Volumn 25, Issue 11, 2009, Pages 2777-2784

  Gisbert, Javier P ^a,b   Cooper, Alun ^c   Karagiannis, Dimitrios ^d   Hatlebakk, Jan ^e   Agréus, Lars ^f   Jablonowski, Helmut ^g   Tafalla, Monica ^h  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Bridge Medical Centre   (United Kingdom)

^d ATHENS MEDICAL CENTER   (Greece)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Klinikum Salzgitter GmbH   (Germany)

^h ASTRAZENECA   (United Kingdom)

Author keywords

Disease management; Gastro oesophageal reflux disease; Healthcare utilisation; Primary care

Indexed keywords

ANTACID AGENT; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONSULTATION; DRUG USE; EUROPE; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; SYMPTOM;

ADULT; AGED; ALGORITHMS; ANTI-ULCER AGENTS; EUROPE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 72549088930     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903314546     Document Type: Article

References (21)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920 (Pubitemid 44166604)
2. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717 (Pubitemid 40559260)
3. Jones R, Liker HR, Ducrotté P. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 2007;61:1301-1307 (Pubitemid 47052376)
4. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004;22:108-114 (Pubitemid 39274305)
5. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and wellbeing in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006;101:18-28 (Pubitemid 43381704)
6. Wahlqvist P, Guyatt GH, Armstrong D, et al. The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation. Pharmacoeconomics 2007;25:385-396 (Pubitemid 46744469)
7. Gisbert JP, Cooper A, Karagiannis D, et al. Consultation rates and characteristics of gastroesophageal reflux disease in primary care: a European observational study. Eur J Gen Pract 2009; in press
8. Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009;7:60
9. Seifert B, Rubin G, de Wit N, et al. The management of common gastrointestinal disorders in general practice. A survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liver Dis 2008;40:659-666
10. Jian R, Hassani Z, El Kebir S, et al. Management of gastro-esophageal reflux disease in primary care. Results from an observational study of 2,474 patients (AO). Gastroenterol Clin Biol 2007;31:72-77
11. Fass R, Shapiro M, Dekel R, et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005;22:79-94
12. Gunaratnam NT, Jessup TP, Inadomi J, et al. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23:1473-1477
13. Hatlebakk JG, Katz PO, Camacho-Lobato L, et al. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther 2000;14:1267-1272 (Pubitemid 30802377)
14. Dent J, Jones R, Vakil N, et al. A management strategy for GERD based on the Gastroesophageal Reflux Disease Questionnaire (GerdQ) [abstract]. Scand J Gastroenterol 2008;43:34-35
15. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-57 (Pubitemid 32104807)
16. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-134 (Pubitemid 18054672)
17. Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007;25:1451-1459 (Pubitemid 46848895)
18. Rey E, Moreno Elola-Olaso C, Rodriguez Artalejo F, et al. Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain. Rev Esp Enferm Dig 2006;98:518-526 (Pubitemid 350104420)
19. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-1391
20. De Giorgi F, Savarese MF, Atteo E, et al. Medical treatment of gastro-oesophageal reflux disease. Acta Otorhinolaryngol Ital 2006;26:276-280
21. King A, MacDonald C, Örn C. Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int J Clin Pract 2008;62:1838-1843